PRELUDE THERAPEUTICS INC (PRLD) Operating cash flow 2019–2025
PRELUDE THERAPEUTICS INC (PRLD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$56.3MFY2025 · since FY2019: -$25.7M → -$56.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$56.3M | +45.3% |
| FY2024 | -$102.9M | +3.9% |
| FY2023 | -$107.1M | -27.9% |
| FY2022 | -$83.7M | -0.2% |
| FY2021 | -$83.5M | -80.9% |
| FY2020 | -$46.2M | -79.9% |
| FY2019 | -$25.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice